Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin.

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Abstract Text:

Zongdong Li,Michael A Nardi,Jing Wu,Ruimin Pan,Wei Zhang,Simon Karpatkin,Zongdong Li,Michael A Nardi,Jing Wu,Ruimin Pan,Wei Zhang,Simon Karpatkin,

We have described an autoantibody against beta3 (GPIIIa49-66), a region of platelet integrin alphaIIbbeta3 that is unique. It induces platelet fragmentation in the absence of complement via antibody activation of platelet NADPH oxidase and 12-lipoxygenase to release reactive oxygen species, which destroy platelets. To study the mechanism of anti-GPIIIa antibody-induced platelet fragmentation, we screened a human single chain Fv antibody library with the GPIIIa49-66 peptide. Nine monoclonal antibodies were identified that were capable of binding to GPIIIa49-66. Surprisingly, binding avidity for GPIIIa49-66 did not correlate with activity of induction of platelet fragmentation. We therefore investigated the requirements for platelet fragmentation. Mutations were introduced into the heavy chain complementary-determining region-3 of clones 11, 43, and 54 by site-directed mutagenesis. The capability of these clones to induce platelet fragmentation or bind to GPIIIa49-66 subsequently changed. Molecular modeling of these clones with their mutants revealed that the ability to induce platelet fragmentation is affected by the side chain orientation of positively charged amino acids in the heavy chain of residues 99-102. Thus, a structural change in the conformation of anti-GPIIIa49-66 antibody contributes to its binding to the beta3 integrin and subsequent antibody-induced platelet fragmentation and aggregate dissolution.

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Publishing Authors By Initials

Z Li,MA Nardi,J Wu,R Pan,W Zhang,S Karpatkin,Z Li,MA Nardi,J Wu,R Pan,W Zhang,S Karpatkin,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of biological chemistry

VOLUME: 283

Page Numbers: 3224-30

Journal Abbreviation: J. Biol. Chem.

ISSN: 0021-9258

DAY: 3

MONTH: 12

YEAR: 2007

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985121

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin.

AFFILIATION: Departments of Medicine and Pediatrics, New York University School of Medicine, New York, New York 10016.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biol Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin Related Publications

• Growth regulated oncogene is pivotal in thrombin-induced angiogenesis.
• Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin.
• Respiratory changes in multiple sclerosis.
• Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis.
• Twist is required for thrombin-induced tumor angiogenesis and growth.